Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/new-psychoactive-substances-nps-psychedelic-experiences-and-FS0ylsDZiL
References (150)
-
R. Middlefell (1967)
The Effects of LSD on Body Sway Suggestibility in a Group of Hospital PatientsBritish Journal of Psychiatry, 113
-
F. Schifano, L. Orsolini, G. Papanti, J. Corkery (2015)
Novel psychoactive substances of interest for psychiatryWorld Psychiatry, 14
-
O. Bowden-Jones, D. Abdulrahim (2020)
Club Drugs and Novel Psychoactive Substances -
José Bouso, Fernanda Palhano-Fontes, A. Rodríguez-Fornells, S. Ribeiro, R. Sanches, J. Crippa, J. Hallak, D. Araujo, J. Riba (2015)
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humansEuropean Neuropsychopharmacology, 25
-
R. Luciano, M. Perazella (2014)
Nephrotoxic effects of designer drugs: synthetic is not better!Nature Reviews Nephrology, 10
-
Bridgette Martinak, Ramy Bolis, J. Black, Rachel Fargason, Badari Birur (2017)
Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.Psychopharmacology bulletin, 47 4
-
M. Nishimura, Kohji Sato (1999)
Ketamine stereoselectively inhibits rat dopamine transporterNeuroscience Letters, 274
-
C. Reissig, L. Carter, Matthew Johnson, M. Mintzer, Margaret Klinedinst, R. Griffiths (2012)
Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensPsychopharmacology, 228
-
R. Sewell, J. Halpern, H. Pope (2006)
Response of cluster headache to psilocybin and LSDNeurology, 66
-
F. Vollenweider, K. Leenders, I. Øye, D. Hell, J. Angst (1997)
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)European Neuropsychopharmacology, 7
-
J. Bruhn, P. Smet, H. El‐Seedi, O. Beck (2002)
Mescaline use for 5700 yearsThe Lancet, 359
-
S. Chiappini, Hugh Claridge, J. Corkery, C. Goodair, B. Loi, F. Schifano (2014)
‘Special M’ related fatalities in the UK. -
F. Massé, M. Hascöet, M. Bourin (2007)
Effect of GABAergic ligands on the anxiolytic-like activity of DOI (a 5-HT2A/2C agonist) in the four-plate test in miceEuropean Neuropsychopharmacology, 17
-
J. Pestaner, Pamela Southall (2003)
Sudden Death During Arrest and Phencyclidine IntoxicationThe American Journal of Forensic Medicine and Pathology, 24
-
M. Caloro, Giuseppa Calabrò, E. Pisa, E. Rosini, G. Kotzalidis, D. Lonati, C. Locatelli, P. Papa, F. Schifano, P. Girardi (2018)
Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic DisorderJournal of Addiction Medicine, 12
-
D. Nichols (2016)
PsychedelicsPharmacological Reviews, 68
-
(1993)
LSD – mein Sorgenkind -
Evelyn Hearne, M. Hout (2016)
“Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm ReductionJournal of Psychoactive Drugs, 48
-
H. El‐Seedi, P. Smet, O. Beck, G. Possnert, J. Bruhn (2005)
Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas.Journal of ethnopharmacology, 101 1-3
-
S. Graziano, L. Orsolini, M. Rotolo, R. Tittarelli, F. Schifano, S. Pichini (2017)
Herbal Highs: Review on Psychoactive Effects and NeuropharmacologyCurrent Neuropharmacology, 15
-
C. Davidson, F. Schifano (2016)
The potential utility of some legal highs in CNS disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry, 64
-
K. Murnane (2018)
The renaissance in psychedelic research: What do preclinical models have to offer.Progress in brain research, 242
-
S. Mendelson (2000)
The current status of the platelet 5-HT(2A) receptor in depression.Journal of affective disorders, 57 1-3
-
L. Orsolini, G. Papanti, D. Berardis, A. Guirguis, J. Corkery, F. Schifano (2017)
The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic ReviewFrontiers in Psychiatry, 8
-
N. Comer, L. Madow, J. Dixon (1967)
Observations of sensory deprivation in a life-threatening situation.The American journal of psychiatry, 124 2
-
I. Bonta (2004)
Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor.Medical hypotheses, 62 1
-
B. Dhonnchadha, M. Hascöet, P. Jolliet, M. Bourin (2003)
Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in miceBehavioural Brain Research, 147
-
David Sheridan, R. Hendrickson, G. Beauchamp, Amber Laurie, R. Fu, B. Horowitz (2016)
Adolescent Intentional Abuse Ingestions: Overall 10-Year Trends and Regional VariationPediatric Emergency Care, 35
-
J. Suzuki, M. Dekker, E. Valenti, Fabiola Cruz, A. Correa, J. Poklis, A. Poklis (2015)
Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.Psychosomatics, 56 2
-
C. Reissig, L. Carter, Matthew Johnson, M. Mintzer, Margaret Klinedinst, R. Griffiths (2012)
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensPsychopharmacology, 223
-
F. Schifano, J. Corkery, A. Oyefeso, T. Tonia, A. Ghodse (2008)
Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006).Journal of clinical psychopharmacology, 28 1
-
Tanya Calvey, F. Howells (2018)
An introduction to psychedelic neuroscience.Progress in brain research, 242
-
D. Tracy, D. Wood, D. Baumeister (2017)
Novel psychoactive substances: types, mechanisms of action, and effectsBritish Medical Journal, 356
-
Shannon Miller (2005)
Dextromethorphan psychosis, dependence and physical withdrawalAddiction Biology, 10
-
Cristina Miliano, G. Serpelloni, C. Rimondo, Maddalena Mereu, M. Marti, M. Luca (2016)
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like StimulantsFrontiers in Neuroscience, 10
-
M. Storck, L. Black, M. Liddell (2016)
Inhalant Abuse and Dextromethorphan.Child and adolescent psychiatric clinics of North America, 25 3
-
Jack Pettigrew (2011)
Iconography in Bradshaw b rock art: breaking the circularityClinical and Experimental Optometry, 94
-
N. Ripoll, B. Dhonnchadha, V. Sébille, M. Bourin, M. Hascöet (2005)
The four-plates test–retest paradigm to discriminate anxiolytic effectsPsychopharmacology, 180
-
S. Chiappini, Hugh Claridge, J. Corkery, C. Goodair, B. Loi, F. Schifano (2015)
Methoxetamine‐related deaths in the UK: an overviewHuman Psychopharmacology: Clinical and Experimental, 30
-
R. Strassman (2000)
DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences -
K. Bonhoeffer
Klinische und anatomische Beiträge zur Kenntnis der Alkoholdelirien.European Neurology, 1
-
L. Lyssenko, C. Schmahl, Laura Bockhacker, R. Vonderlin, M. Bohus, N. Kleindienst (2018)
Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale.The American journal of psychiatry, 175 1
-
T. Krebs, P. Johansen (2013)
Psychedelics and Mental Health: A Population StudyPLoS ONE, 8
-
S. Karami, J. Major, S. Calderon, Jana Mcaninch (2018)
Trends in dextromethorphan cough and cold products: 2000–2015 National Poison Data System intentional abuse exposure callsClinical Toxicology, 56
-
M. Bernhard, K. Ulrich (2009)
[Recurrent cortical blindness after LSD-intake].Fortschritte der Neurologie-Psychiatrie, 77 2
-
R. Burns, S. Lerner (1978)
Phencyclidine deaths.JACEP, 7 4
-
Matthew Johnson, R. Sewell, R. Griffiths (2012)
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and alcohol dependence, 123 1-3
-
S. Grof, L. Goodman, W. Richards, A. Kurland (1973)
LSD-assisted psychotherapy in patients with terminal cancer.International pharmacopsychiatry, 8 3
-
F. Schifano, L. Orsolini, D. Papanti, J. Corkery (2016)
NPS: Medical Consequences Associated with Their Intake.Current topics in behavioral neurosciences, 32
-
D. Levine (2007)
‘Pharming’: the abuse of prescription and over-the-counter drugs in teensCurrent Opinion in Pediatrics, 19
-
F. Schifano (2018)
Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) PhenomenonBrain Sciences, 8
-
J. Wallach, Heather Kang, Tristan Colestock, Hamilton Morris, Z. Bortolotto, G. Collingridge, D. Lodge, A. Halberstadt, S. Brandt, A. Adejare (2016)
Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and AnaloguesPLoS ONE, 11
-
G. Martinotti, M. Nicola, D. Quattrone, R. Santacroce, F. Schifano, R. Murray, M. Giannantonio (2015)
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma, 21
-
Andrew Moskowitz, G. Heim (2011)
Eugen Bleuler's Dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration.Schizophrenia bulletin, 37 3
-
R. Shelton, R. Shelton, E. sanders-Bush, Manier Dh, Manier Dh, D. Lewis, D. Lewis (2009)
Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase ANeuroscience, 158
-
A. Smith, J. Ott, J. Bigwood (1979)
Teonanacatl: Hallucinogenic Mushrooms of North AmericaMycologia, 71
-
E. Bleuler (1968)
[Dementia praecox or the group of schizophrenias].Vertex, 21 93
-
L. Orsolini, M. Ciccarese, D. Papanti, D. Berardis, A. Guirguis, J. Corkery, F. Schifano (2018)
Psychedelic Fauna for Psychonaut Hunters: A Mini-ReviewFrontiers in Psychiatry, 9
-
M. Balíková (2005)
Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.Forensic science international, 153 1
-
Chrislean Botanas, J. Peña, H. Kim, Yong Lee, J. Cheong (2019)
Methoxetamine: A foe or friend?Neurochemistry International, 122
-
M. Ríos (1971)
Ayahuasca—The Healing VineInternational Journal of Social Psychiatry, 17
-
M. Kometer, A. Schmidt, L. Jäncke, F. Vollenweider (2013)
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsThe Journal of Neuroscience, 33
-
R. Dupont (1988)
Abuse of benzodiazepines: the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc.The American journal of drug and alcohol abuse, 14 Suppl 1
-
K. Jansen (2004)
Ketamine: Dreams and Realities -
F. Romanelli, Kelly Smith (2009)
Dextromethorphan abuse: clinical effects and management.Journal of the American Pharmacists Association : JAPhA, 49 2
-
S. deRoux, Anthony Sgarlato, E. Marker (2011)
Phencyclidine: A 5‐Year Retrospective Review from the New York City Medical Examiner’s OfficeJournal of Forensic Sciences, 56
-
P. Simonato, O. Corazza, P. Santonastaso, J. Corkery, P. Deluca, Z. Davey, Ursula Blaszko, F. Schifano (2013)
Novel psychoactive substances as a novel challenge for health professionals: results from an Italian surveyHuman Psychopharmacology: Clinical and Experimental, 28
-
O. Mason, C. Morgan, S. Dhiman, A. Patel, N. Parti, H. Curran (2008)
Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosisPsychological Medicine, 39
-
Brett Lu, C. Woofter, R. Escalona (2004)
A case of prolonged peyote-induced psychosis resolved by sleep.The Journal of clinical psychiatry, 65 10
-
Francisco Moreno, Christopher Wiegand, E. Keolani, Taitano, Pedro Delgado (2006)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry, 67 11
-
M. Andreasen, R. Telving, R. Birkler, Bente Schumacher, M. Johannsen (2009)
A fatal poisoning involving Bromo-Dragonfly.Forensic science international, 183 1-3
-
M. Bogenschutz, Alyssa Forcehimes, Jessica Pommy, C. Wilcox, P. Barbosa, R. Strassman (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology, 29
-
O. Corazza, F. Schifano, P. Simonato, S. Fergus, S. Assi, J. Stair, J. Corkery, G. Trincas, P. Deluca, Z. Davey, Ursula Blaszko, Z. Demetrovics, J. Moskalewicz, Aurora Enea, G. Melchiorre, Barbara Mervó, L. Furia, M. Farré, Liv Flesland, Manuela Pasinetti, C. Pezzolesi, A. Pisarska, H. Shapiro, H. Siemann, A. Skutle, E. Sferrazza, M. Torrens, P. Kreeft, Daniela Zummo, N. Scherbaum (2012)
Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamineHuman Psychopharmacology: Clinical and Experimental, 27
-
E. Studerus, A. Gamma, F. Vollenweider (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)PLoS ONE, 5
-
A. Pringle, S. Zwolinsky (2014)
No effects without side effects!Perspectives in Public Health, 134
-
Katharina Hofer, Bettina Grager, D. Müller, C. Rauber-Lüthy, H. Kupferschmidt, K. Rentsch, A. Ceschi (2012)
Ketamine-like effects after recreational use of methoxetamine.Annals of emergency medicine, 60 1
-
D. Araujo, S. Ribeiro, G. Cecchi, F. Carvalho, T. Sanchez, J. Pinto, B. Martinis, J. Crippa, J. Hallak, Antônio Santos (2012)
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestionHuman Brain Mapping, 33
-
David Dadiomov, Kelly Lee (2019)
The effects of ketamine on suicidality across various formulations and study settingsThe Mental Health Clinician, 9
-
P. Dargan, H. Tang, W. Liang, David Wood, D. Yew (2014)
Three months of methoxetamine administration is associated with significant bladder and renal toxicity in miceClinical Toxicology, 52
-
Z. Bhagwagar, R. Hinz, M. Taylor, Sabrina Fancy, P. Cowen, P. Grasby (2006)
Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.The American journal of psychiatry, 163 9
-
S. Barker (2018)
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and FunctionFrontiers in Neuroscience, 12
-
F. Greifenstein, M. Devault, J. Yoshitake, J. Gajewski (1958)
A STUDY OF A 1‐ARYL CYCLO HEXYL AMINE FOR ANESTHESIA*Anesthesia & Analgesia, 37
-
Hamilton Morris, J. Wallach (2014)
From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.Drug testing and analysis, 6 7-8
-
T. Noguchi, G. Nakamura (1978)
Phencyclidine-related deaths in Los Angeles County, 1976.Journal of forensic sciences, 23 3
-
C. Savage (1952)
Lysergic acid diethylamide; a clinical-psychological study.The American journal of psychiatry, 108 12
-
A. Maatz, P. Hoff, J. Angst (2015)
Eugen Bleuler's schizophrenia—a modern perspectiveDialogues in Clinical Neuroscience, 17
-
M. Zentner, D. Grandjean, K. Scherer (2008)
Emotions evoked by the sound of music: characterization, classification, and measurement.Emotion, 8 4
-
M. Bogenschutz, Alyssa Forcehimes, Jessica Pommy, E. Claire, Wilcox, P. Barbosa, R. Strassman (2016)
Psilocybin-assisted treatment for alcohol dependence A proof-of-concept study by -
B. Roth, S. Gibbons, W. Arunotayanun, Xi-Ping Huang, V. Setola, R. Treble, L. Iversen (2013)
The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA ReceptorPLoS ONE, 8
-
Bruce Greyson, Ian Stevenson (1980)
The phenomenology of near-death experiences.The American journal of psychiatry, 137 10
-
M. Bickel, T. Ditting, H. Watz, A. Roesler, S. Weidauer, V. Jacobi, Saskia Gueller, C. Betz, S. Fichtlscherer, J. Stein (2005)
Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 12 6
-
Joe Buskirk, P. Griffiths, M. Farrell, L. Degenhardt (2017)
Trends in new psychoactive substances from surface and "dark" net monitoring.The lancet. Psychiatry, 4 1
-
R. Carhart-Harris, Robert Leech, T. Williams, D. Erritzoe, N. Abbasi, T. Bargiotas, P. Hobden, David Sharp, John Evans, A. Feilding, Richard Wise, David Nutt (2012)
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry : the journal of mental science, 200 3
-
J. Corkery, Hugh Claridge, B. Loi, C. Goodair, F. Schifano (2014)
Drug-related deaths in the UK: January-December 2012 : Annual report 2013 -
J. Meyer, S. McMain, S. Kennedy, L. Korman, Gregory Brown, J. DaSilva, Alan Wilson, Thomas Blak, Rahel Eynan-Harvey, Verdell Goulding, S. Houle, P. Links (2003)
Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.The American journal of psychiatry, 160 1
-
D. Baumeister, L. Tojo, D. Tracy (2015)
Legal highs: staying on top of the flood of novel psychoactive substancesTherapeutic Advances in Psychopharmacology, 5
-
Y. Sheline, M. Mintun, D. Barch, Consuelo Wilkins, A. Snyder, S. Moerlein (2004)
Decreased Hippocampal 5-HT2A Receptor Binding in Older Depressed Patients Using [18F]Altanserin Positron Emission TomographyNeuropsychopharmacology, 29
-
J. Eastman, S. Cohen (1975)
Hypertensive crisis and death associated with phencyclidine poisoning.JAMA, 231 12
-
J. Wallach, S. Brandt (2018)
1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.Handbook of experimental pharmacology, 252
-
A. Guirguis (2017)
New psychoactive substances: a public health issueInternational Journal of Pharmacy Practice, 25
-
C. Morgan, L. Monaghan, H. Curran (2004)
Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.Addiction, 99 11
-
Alphonse Poklis, Michael Graham, Diane Maginn, Carrie Branch, George Gantner (1990)
Phencyclidine and violent deaths in St. Louis, Missouri: a survey of medical examiners' cases from 1977 through 1986.The American journal of drug and alcohol abuse, 16 3-4
-
E. Domino (1992)
Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonistsJournal of Psychopharmacology, 6
-
W. Pahnke, A. Kurland, L. Goodman, W. Richards (1969)
LSD-assisted psychotherapy with terminal cancer patients.Current psychiatric therapies, 9
-
Matthew Johnson, A. Garcia-Romeu, Mary Cosimano, R. Griffiths (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionJournal of Psychopharmacology, 28
-
M. Karst, J. Halpern, M. Bernateck, T. Passie (2010)
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case seriesCephalalgia, 30
-
O. Corazza (2008)
Near-death experiences -
S. Turton, D. Nutt, R. Carhart-Harris (2015)
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.Current drug abuse reviews, 7 2
-
M. Persinger (1983)
Religious and Mystical Experiences as Artifacts of Temporal Lobe Function: A General HypothesisPerceptual and Motor Skills, 57
-
(1969)
translated from the original German (LSD -
A. Kemp (2001)
Life After LifeScience, 292
-
J. Arditti, Michel Spadari, L. deHaro, A. Brun, J. Bourdon, M. Valli (2002)
[Ketamine--dreams and realities].Acta clinica Belgica, 57 Suppl 1
-
M. Raval, R. Gaba, Katherine Brown, Kent Sato, M. Eskandari (2008)
Percutaneous transluminal angioplasty in the treatment of extensive LSD-induced lower extremity vasospasm refractory to pharmacologic therapy.Journal of vascular and interventional radiology : JVIR, 19 8
-
Burns Rs, Lerner Se, R. Corrado, James Sh, Schnoll Sh (1975)
Phencyclidine--states of acute intoxication and fatalities.The Western journal of medicine, 123 5
-
L. Orsolini, P. John-Smith, D. McQueen, D. Papanti, J. Corkery, F. Schifano (2017)
Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?Current Neuropharmacology, 15
-
Alexandra Forrest, C. Coto, S. Siegel (2014)
Animal Models of Psychosis: Current State and Future DirectionsCurrent Behavioral Neuroscience Reports, 1
-
C. Grob, J. Callaway, G. Brito, E. Neves, Guilherme Oberlaender, Oswaldo Saide, E. Labigalini, C. Tacla, C. Miranda, R. Strassman, K. Boone (1996)
Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in BrazilThe Journal of Nervous and Mental Disease, 184
-
Y. Schmid, Florian Enzler, Peter Gasser, E. Grouzmann, K. Preller, F. Vollenweider, R. Brenneisen, F. Müller, S. Borgwardt, M. Liechti (2015)
Acute Effects of Lysergic Acid Diethylamide in Healthy SubjectsBiological Psychiatry, 78
-
J. Halpern, A. Lerner, T. Passie (2018)
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.Current topics in behavioral neurosciences, 36
-
M. Kometer, A. Schmidt, R. Bachmann, E. Studerus, E. Seifritz, F. Vollenweider (2012)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic SubreceptorsBiological Psychiatry, 72
-
O. Corazza, F. Schifano (2010)
Near-Death States Reported in a Sample of 50 MisusersSubstance Use & Misuse, 45
-
Mike Fitzpatrick (2003)
Special KThe Lancet, 361
-
D. Gregorio, J. Enns, N. Nuñez, L. Posa, G. Gobbi (2018)
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.Progress in brain research, 242
-
A. Roy, Chenen Hsieh, K. Crapanzano (2015)
Dextromethorphan Addiction Mediated Through the NMDA System: Common Pathways With Alcohol?Journal of addiction medicine, 9 6
-
Huixi Dong, Cheng Yang, Yidong Shen, Liang Liu, Mengqi Liu, W. Hao (2019)
Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjectsThe American Journal of Drug and Alcohol Abuse, 45
-
P. Dell, J. O'Neil (2010)
Dissociation and the Dissociative Disorders : DSM-V and Beyond -
J. Halpern, A. Sherwood, J. Hudson, D. Yurgelun-Todd, H. Pope (2005)
Psychological and Cognitive Effects of Long-Term Peyote Use Among Native AmericansBiological Psychiatry, 58
-
Robin Carhart-Harris, M. Kaelen, M. Whalley, M. Bolstridge, A. Feilding, David Nutt (2014)
LSD enhances suggestibility in healthy volunteersPsychopharmacology, 232
-
B. Liskow (1980)
Plants of the Gods: Origins of Hallucinogenic UseJAMA, 244
-
O. Corazza, S. Assi, F. Schifano (2013)
From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and MethoxetamineCNS Neuroscience & Therapeutics, 19
-
G. Pandey, Yogesh Dwivedi, H. Rizavi, Xinguo Ren, S. Pandey, C. Pesold, R. Roberts, R. Conley, C. Tamminga (2002)
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims.The American journal of psychiatry, 159 3
-
Psilocybin , mystical - type experiences , and the treatment of symptoms of anxiety and depression in patients with a life - threatening cancer diagnosis -
E. Lear (1968)
INTRAVENOUS ANESTHESIA ..... a survey of newer agentsAnesthesia & Analgesia, 47
-
Z. Berrens, J. Lammers, C. White (2010)
Rhabdomyolysis After LSD Ingestion.Psychosomatics, 51 4
-
B. Sjoberg, L. Hollister (1965)
The effects of psychotomimetic drugs on primary suggestibilityPsychopharmacologia, 8
-
R. Carhart-Harris, D. Erritzoe, T. Williams, J. Stone, L. Reed, A. Colasanti, R. Tyacke, R. Leech, A. Malizia, K. Murphy, P. Hobden, J. Evans, A. Feilding, R. Wise, D. Nutt (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinProceedings of the National Academy of Sciences, 109
-
E. Luby, B. Cohen, G. Rosenbaum, J. Gottlieb, R. Kelley (1959)
Study of a new schizophrenomimetic drug; sernyl.A.M.A. archives of neurology and psychiatry, 81 3
-
P. John-Smith, D. McQueen, L. Edwards, F. Schifano (2013)
Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspectiveHuman Psychopharmacology: Clinical and Experimental, 28
-
J. Meyer (2012)
Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and PreventionClinical Pharmacology & Therapeutics, 91
-
E. Joyce (2018)
Organic psychosis: The pathobiology and treatment of delusionsCNS Neuroscience & Therapeutics, 24
-
T. Waelbers, I. Polis, S. Vermeire, A. Dobbeleir, J. Eersels, B. Spiegeleer, K. Audenaert, G. Slegers, K. Peremans (2013)
5-HT2A Receptors in the Feline Brain: 123I-5-I-R91150 Kinetics and the Influence of Ketamine Measured with Micro-SPECTThe Journal of Nuclear Medicine, 54
-
G. Martinotti, R. Santacroce, M. Pettorruso, C. Montemitro, M. Spano, M. Lorusso, M. Giannantonio, A. Lerner (2018)
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic PerspectivesBrain Sciences, 8
-
W. Pahnke, A. Kurland, S. Unger, C. Savage, S. Wolf, L. Goodman (1970)
Psychedelic Therapy (Utilizing LSD) with Cancer PatientsJournal of Psychoactive Drugs, 3
-
Burns Rs, Lerner Se (1978)
Causes of phencyclidine-related deaths.Clinical Toxicology, 12
-
W. Pahnke, A. Kurland, S. Unger, C. Savage, S. Grof (1970)
The experimental use of psychedelic (LSD) psychotherapy.JAMA, 212 11
-
D. Spangler, Catherine Loyd, Emily Skor (2016)
Dextromethorphan: a case study on addressing abuse of a safe and effective drugSubstance Abuse Treatment, Prevention, and Policy, 11
-
F. Schifano, D. Papanti, L. Orsolini, J. Corkery (2016)
Novel psychoactive substances: the pharmacology of stimulants and hallucinogensExpert Review of Clinical Pharmacology, 9
-
W. Feuerlein (1969)
[Drug addiction and drug abuse].Munchener medizinische Wochenschrift, 111 50
-
E. Brandrup, T. Vanggaard (1977)
LSD treatment in a severe case of compulsive neurosisActa Psychiatrica Scandinavica, 55
-
A. Halberstadt, Natalia Slepak, J. Hyun, Mahálah Buell, S. Powell (2016)
The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodentsPsychopharmacology, 233
- Publisher
- Springer Journals
- Copyright
- Copyright © 2019 by Springer Nature Switzerland AG
- Subject
- Medicine & Public Health; Psychiatry; Neurology
- eISSN
- 2196-2952
- DOI
- 10.1007/s40429-019-00249-z
- Publisher site
- See Article on Publisher Site
Abstract
Purpose of the Review A significant increase in the number, type and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic substances have histori- cally been used in order to achieve altered states of consciousness such as dissociative states. We aimed here at describing both a large number of novel ketamine-like dissociatives and tryptamine/lysergamide/phenethylamine psychedelics available, whilst describing the acute/long-term clinical scenarios most commonly associated with their intake. Recent Findings An updated overview of the clinical and clinical pharmacological issues related to some of the most popular NPS categories has been provided, describing both psychosis and remaining psychopathological issues related to them. Conclusions Although the complex link between NPS and psychiatric illnesses is yet to be fully understood, NPS misuse is now a significant clinical issue and an increasing challenge for clinicians working in both mental health and emergency departments. . . . . . Keywords New psychoactive substances NPS Dissociation Psychedelics Drug-induced psychosis Drug misuse This article is part of the Topical Collection on Dissociation and Addictive Behaviors * Stefania Chiappini Psychopharmacology, Drug Misuse and Novel Psychoactive stefaniachiappini9@gmail.com Substances Research Unit, School of Life and Medical Sciences,
Journal
Current Addiction Reports – Springer Journals
Published: Apr 23, 2019